{"id":328319,"date":"2026-10-27T12:35:01","date_gmt":"2026-10-27T07:05:01","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=328319"},"modified":"2026-10-27T12:35:01","modified_gmt":"2026-10-27T07:05:01","slug":"us-generics-and-branded-medicines-company-global-generics-maker-and-chronic-therapy-brands-company-stocks-roadmap-paragon-list","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/us-generics-and-branded-medicines-company-global-generics-maker-and-chronic-therapy-brands-company-stocks-roadmap-paragon-list\/","title":{"rendered":"3 US Generics and Branded Medicines Company, Global Generics Maker and Chronic Therapy Brands Company Stocks With a Strong Future Roadmap: Alembic Pharmaceuticals, Dr. Reddy’s Laboratories and Eris Lifesciences"},"content":{"rendered":"

Alembic Pharmaceuticals, Dr. Reddy’s Laboratories and Eris Lifesciences: ROE of 11.1% to 15.9% and FY22 to FY26 revenue CAGR of 8.4% to 22.9%. Prices as of 26 Oct 2026.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

The three US generics and chronic brand pharma stocks to watch are Alembic Pharmaceuticals, Dr. Reddy’s Laboratories and Eris Lifesciences. Their return on equity ranges from 11.1% to 15.9%, and their revenue compound annual growth from FY22 to FY26 ranges from 8.4% to 22.9%. Eris Lifesciences leads on both return on equity at 15.9% and revenue growth at 22.9% a year. Prices are based on the 26 October 2026 close, and this article is educational, not investment advice.<\/p>\n<\/div>\n

US generics and chronic brand pharma stocks offer a focused view of a sector where demand keeps widening. Alembic Pharmaceuticals, Dr. Reddy’s Laboratories and Eris Lifesciences cover a US generics and branded medicines company, a global generics maker and a chronic therapy brands company.<\/p>\n

This list covers three US generics and chronic brand pharma stocks with complete current figures: Alembic Pharmaceuticals, Dr. Reddy’s Laboratories and Eris Lifesciences. Every figure comes from the latest reported financials and the 26 October 2026 market close. Companies without complete current figures were left out.<\/p>\n

Click Here – Get Free Investment Predictions<\/a><\/strong><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n